Items

• Comparative Efficacy of High-Dose Dexamethasone Versus Methylprednisolone in Coronavirus Disease 2019 (COVID-19)-Associated Acute Respiratory Distress Syndrome (2024-03)

  P. Kovačević, J. Malić, T. Kovačević, S. Dragić, B. Zlojutro, M. Jandrić, D. Momčičević, B. Đajić-Čančarević, R. Škrbić, M. Rizwan, Comparative Efficacy of High-Dose Dexamethasone Versus Methylprednisolone in Coronavirus Disease 2019 (COVID-19)-Associated Acute Respiratory Distress Syndrome, The Cureus Journal of Medical Science: Peer-Reviewed, Open Access, Vol. 16, No. 3, Mar, 2024

• Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study (2024-05)

  P. Kovačević, D. Milaković, T. Kovačević, V. Barišić, S. Dragić, B. Zlojutro, B. Miljković, K. Vučićević, Z. Rizwan, Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study, NAUNYN-SCHMIEDEBERG`S ARCHIVES OF PHARMACOLOGY, Vol. 397, pp. 7747 - 7756, May, 2024